Regular use of analgesics is a risk factor for venal cell carcinoma

British Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 542-548

  Gago Dominguez, M ^a   Yuan, J M ^a   Castelao, J E ^a   Ross, R K ^a   Yu, M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acetaminophen; Analgesics; Aspirin; NSAID; Phenacetin; Renal cell cancer

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENACETIN;

ADULT; AGED; ARTICLE; CANCER STATISTICS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG CARCINOGENICITY; DRUG FORMULATION; DRUG USE; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY PELVIS TUMOR; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS; ASPIRIN; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHNIC GROUPS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOS ANGELES; MALE; MIDDLE AGED; PHENACETIN; RISK FACTORS;

EID: 0032854618     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690728     Document Type: Article

References (57)

1. Adams DH, Howie AJ, Michael J, McConkey B, Bacon PA and Adu D (1986) Nonsteroidal anti-inflammatory drugs and renal failure. Lancet 1: 57-60
2. Antiplatelet Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infaretion, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308: 81-106
3. Armstrong B, Garrod A and Doll R (1976). A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer 33: 127-136
4. Asal NR, Geyer JR, Risser DR, Lee ET, Kadamani S and Cherng N (1988) Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect Prev 13: 263-279
5. Bengtsson U, Angervall L, Ekman H and Lehmann L (1968) Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 2: 145-150
6. Breslow NE and Day NE (1980) Statistical Methods in Cancer Research, Volume I: The Analysis of Case-Control Studies. IARC Scientific publications 32, IARC: Lyon, France
7. Brodic BB and Axelrod J (1949) The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther 97: 58-67
8. Burrell JH, Yong JL and Macdonald GJ (1991) Analgesic nephropathy in Fischer 344 rats: comparative effects of chronic treatment with either aspirin or paracetamol. Pathology 23: 107-114
9. Consumer Expenditure Study (1985) Product Marketing for Beauty Industry Retailers and Manufacturers 14: 19-20
10. Derby LE and Jick H (1996) Acetaminophen and renal and bladder cancer. Epidemiology 7: 358-362
11. Devesa SS, Silverman DT, McLaughlin JK, Brown CC, Connelly RR and Fraumeni JF Jr (1990) Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control 1: 133-141
12. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and Dubois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188
13. Emeigh Hart SG, Beierschmitt WP, Bartolone JB, Wyand DS, Khairallah EA and Cohen SD (1991) Evidence against deacetylation and for cytochrome P450 mediated activation in acetaminophen-induced nephrotoxicity in the CD-1 mouse. Toxicol Appl Pharmacol 107: 1-15
14. Flaks A and Flaks B (1983) Induction of liver cell tumours in IF mice by paracetamol. Carcinogenesis 4: 363-368
15. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC and Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614
16. Gobé GC and Axelsen RA (1991) The role of apoptosis in the development of renal cortical tubular atrophy associated with healed experimental renal papillary necrosis. Pathology 23: 213-223
17. Henderson BE, Ross RK and Pike MC (1991) Toward the primary prevention of cancer. Science 254: 1131-1138
18. International Agency for Research on Cancer (1987) Analgesic mixtures containing phenacetin. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Updating of IARC Monographs (Vol 1-42), pp. 310-312. IARC: Lyon, France
19. Jensen OM, Knudsen JB, Tomasson H and Sorensen BL (1989) The Copenhagen case-control study of renal pelvis and ureter cancer: role of analgesics. Int J Cancer 44: 965-968
20. Johansson SL (1981) Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen). Int J Cancer 27: 521-529
21. Kari F, Bucher J, Haseman J, Eustis S and Huff J (1995) Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Jpn J Cancer Res 86: 252-263
22. Kokmen E, Beard CM, O'Brien PC, Offord KP and Kurland LT (1993) Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 43: 1887-1892
23. Kreiger N, Marrett LD, Dodds L, Hilditch S and Darlington GA (1993) Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Caus Contr 4: 101-110
24. Kyle ME and Kocsis JJ (1985) The effect of age on salicylate-induced nephrotoxicity in male rats. Toxicol Appl Pharmacol 81: 337-347
25. Liu L, Deapen D, Bernstein L and Ross R (1998) Cancer in Los Angeles County: Incidence and Mortality by Race/Ethnicity 1988-1995. Los Angeles County Cancer Surveillance Program. University of Southern California: Los Angeles, CA
26. McCredie M, Ford JM, Taylor JS and Stewart JH (1982) Analgesics and cancer of the renal pelvis in New South Wales. Cancer 49: 2617-2625
27. McCredie M, Ford JM and Stewart JH (1988) Risk factors for cancer of the renal parenchyma. Int J Cancer 42: 13-16
28. McCredie M, Stewart JH and Day NE (1993) Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer 53: 245-249
29. McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B and Niwa S (1995) International renal-cell cancer study. II. Analgesics Int J Cancer 60: 345-349
30. McGeer PL, Schulzer M and McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologie studies. Neurology 47: 425-432
31. McLaughlin JK, Blot WJ, Mehl ES and Fraumeni JF Jr (1985) Relation of analgesic use to renal cancer: population-based findings. Natl Cancer Inst Monogr 69: 217-222
32. Maclure M and MacMahon B (1985) Phenacetin and cancers of the urinary tract. N Engl J Med 313: 1479-1480
33. McMurtry RJ, Snodgrass WR and Mitchell JR (1978) Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol 46: 87-100
34. Mahony JF, Storey BG, Ibanez RC and Stewart JH (1977) Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust N Z J Med 7: 463-469
35. Mellemgaard A, Niwa S, Mehl ES, Engholm G, McLaughlin JK and Olsen JH (1994) Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 23: 923-930
36. Meyer JS, Rogers RL, McClintic K, Mortel KF and Lotfi J (1989) Randomized clinical trial of daily aspirin therapy in multi infaret dementia. A pilot study. J Am Geriatr Soc 37: 549-555
37. Mitchell JR, McMurtry RJ, Statham CN and Nelson SD (1977) Molecular basis for several drug-induced nephropathies. Am J Med 62: 518-526
38. Nakanishi K, Kurata Y, Oshima M, Fukushima S and Ito N (1982) Carcinogenicity of phenacetin: long-term feeding study in B6c3fl mice. Int J Cancer 29: 439-444
39. Nanra RS (1983) Renal effects of antipyretic analgesics. Am J Med 75: 70-81
40. National Center for Health Statistics (1996) Vital Statistics of the United States, 1992: Vol 2. Mortality, Part A. Hyattsville MD: US Dept of Health and Human Services, Public Health Service. CDC: 1996. United States Department of Health and Human Services publication PHS 96-1101
41. Paganini-Hill A, Chao A, Ross RK and Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 299: 1247-1250
42. Parker SL, Tong T, Bolden S and Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46: 5-27
43. Perneger TV, Whelton PK and Klag MJ (1994) Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti inflammatory drugs. N Engl J Med 331: 1675-1679
44. Plummer DT, Leathwood PD and Blake ME (1975) Urinary enzymes and kidney damage by aspirin and phenacetin. Chem Biol Interact 10: 277-284
45. Pommer W, Bronder E, Greiser E, Helmert H, Jesdinsky HJ, Klimpel A, Borner K and Molzahn M (1989) Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 9: 403-412
46. Prescott LF (1982) Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs 23: 75-149
47. Rosenberg L, Rao RS, Palmer JR, Strom BL, Zauber A, Warshauer ME, Stolley PD and Shapiro S (1998) Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Caus Contr 9: 83-88
48. Ruffin MT, Krishnan K, Rock CL, Normolle D, Vaerten MA, Peters-Golden M, Crowell J, Kelloff G, Boland CR and Brenner DE (1997) Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst 89: 1152-1160
49. Sabatini S (1996). Pathophysiologic mechanisms in analgesic-induced papillary necrosis. Am J Kidney Dis 28: S34-S38
50. Sandler DP, Smith JC, Weinberg CR, Buckalew VM Jr, Dennis VW, Blythe WB and Burgess WP (1989) Analgesic use and chronic renal disease. N Engl J Med 320: 1238-1243
51. Sandler DP, Burr FR and Weinberg CR (1991) Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Am Intern Med 115: 165-172
52. Segasothy M, Samad SA, Zulfigar A and Bennett WM (1994) Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 24: 17-24
53. Steering Committee of the Physicians' Health study Research Group (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321: 129-135
54. Tsuda H, Sakata T, Masui T, Imaida K and Ito N (1984) Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine. Carcinogenesis 5: 525-531
55. Yu MC, Yuan J-M and Ross RK (1999) Epidemiology of renal cell carcinoma. Carcinoma of the Kidney, Testis and Rare Urologic Malignancies: Innovations in Management. pp. 3-13. Springer-Verlag: Berlin, Heidelberg
56. Yuan J-M, Castelao JE, Gago-Dominguez M, Ross RK and Yu MC (1998a) Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77: 1508-1513
57. Yuan J-M, Castelao JE, Gago-Dominguez M, Yu MC and Ross RK (1998b) Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 7: 429-433